Style | Citing Format |
---|---|
MLA | Rahimzade M, et al.. "The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study." Journal of Diabetes and Metabolic Disorders, vol. 24, no. 1, 2025, pp. -. |
APA | Rahimzade M, Farshbafkhalili A, Karimi M, Abolhasanpour N, Kazemi AH, Mirzaei M (2025). The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study. Journal of Diabetes and Metabolic Disorders, 24(1), -. |
Chicago | Rahimzade M, Farshbafkhalili A, Karimi M, Abolhasanpour N, Kazemi AH, Mirzaei M. "The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study." Journal of Diabetes and Metabolic Disorders 24, no. 1 (2025): -. |
Harvard | Rahimzade M et al. (2025) 'The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study', Journal of Diabetes and Metabolic Disorders, 24(1), pp. -. |
Vancouver | Rahimzade M, Farshbafkhalili A, Karimi M, Abolhasanpour N, Kazemi AH, Mirzaei M. The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study. Journal of Diabetes and Metabolic Disorders. 2025;24(1):-. |
BibTex | @article{ author = {Rahimzade M and Farshbafkhalili A and Karimi M and Abolhasanpour N and Kazemi AH and Mirzaei M}, title = {The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {24}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Rahimzade M AU - Farshbafkhalili A AU - Karimi M AU - Abolhasanpour N AU - Kazemi AH AU - Mirzaei M TI - The Prevalence of Herbal Medicine Use and Related Factors Among Diabetic Patients in Tabriz, Iran, 2023: A Cross-Sectional Study JO - Journal of Diabetes and Metabolic Disorders VL - 24 IS - 1 SP - EP - PY - 2025 ER - |